However, there are more biological drugs targeting beta-amyloid in research, and many other treatments in clinical ...

It is estimated that less than one in ten people with dementia are eligible for treatment with Lecanemab or Leqembi, the ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.

A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...

Dementia treatment is more than just medication. It can include lifestyle changes, multimodal therapy, and environmental management, as well. Your dementia treatment plan will depend on underlying ...

Researchers at Monash University are conducting clinical trials of a drug that promises to be a game-changer for sufferers of ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

A once-a-day pill that targets the production of the stress hormone cortisol in the brain has the potential to be the “holy ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

However, the ratio of p-tau181 to amyloid-beta 42 was significantly reduced with nilotinib treatment (P ... investigate this ...